Search Results

A4c - ST Community Toolkits_03 Age 12-15

Disclosure Ref 2025158 - Data Protection Services.pdf

Disclosure Ref 2025158 relating to Procurement of external Data Protection Officer (DPO) & Data protection GDPR compliance services for the period 2022 to 2025

GD11 Assessment Toolkit Guide - Values Based Recruitment – Appendix 1 – Values-Based Recruitment (VBR) Toolkit.docx

Discharge Medicines Service privacy notice - Oct 2025.docx

Derbyshire Community Healthcare Services NHS Foundation Trust (DCHS) will be contacting named community pharmacies on behalf of patients, to ensure that their medicines, care and follow up is managed once they are discharged from our clinical services. This is known as the discharge medicines service. This is to enable community pharmacies to fulfil the national essential service contract from NHS England. This Discharge Medicines Service - Privacy notice outlines the process for this and the benefits

Procedures for the Secure Transfer of Information v3.5.docx

The purpose of this document is to summarise the procedures that staff should follow when transmitting patient and personal information. Other DCHS NHS Trust policies contain more detailed information on the responsibilities of staff in relation to confidentiality and information security, and therefore all staff should ensure they have read and understood their full responsibilities in these areas.

Clinical Effectiveness Policy (P85)

The purpose of this policy is to set out the rationale for clinical audit and provide a framework for such activity, including standards, guidance and procedures, as well as details of the support available from the Clinical Effectiveness Team: • For registering and approving clinical audit project proposals • For developing and designing clinical audit projects • To ensure clinical audit leads to improvement when a need for improvement is identified This policy aims to support a culture of best practice in the management and delivery of clinical audit, to clarify the roles and responsibilities of all staff involved, and to promote a culture of quality improvement in our services.

Mental Health Act 1983 Procedure for Associate Hospital Managers Hearings Policy and Procedure (P78)

To provide guidance to Trust staff when considering the use of urgent treatment to patients detained in hospital under the MHA 1983, or subject to a Community Treatment Order.

DCHS Safeguarding Supervision Policy (P15)

Safeguarding supervision is recognised by DCHS FT as an important element within clinical supervision and the safety culture. In addition to an individual’s knowledge, skills, experience and training, effective safeguarding practice relies on a professional’s curiosity and vigilance. Safeguarding supervision provides an opportunity to both sustain and foster these qualities and ensure staff are updated on current safeguarding issues, legislation and outcomes of recent Child Practice Reviews (CPR), Serious Incident Learning Reviews (SILR), Domestic Homicide Reviews (DHR), and Safeguarding Adult Reviews (SAR). This policy covers both Adult and Children

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Media Consent Form - 2024

Media consent form